Read more about Niraparib Approved for Maintenance Treatment of Ovarian Cancer
Mar 28, 2017
Niraparib Approved for Maintenance Treatment of Ovarian Cancer
...to be approved by the FDA that does not require BRCA mutation or other biomarker testing. TESARO anticipates launching niraparib in the United States in late April. READ MORE… 11...